Drug Trial Radar · NCT06452147
Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial)
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,860
Planned (sponsor's estimate)
Start
Jun 19, 2024
Primary completion
Jul 30, 2028
Study completion Oct 31, 2028
Sponsor
- Lead sponsor
- Second Affiliated Hospital of Wenzhou Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Zhejiang Provincial People's Hospital; First Affiliated Hospital of Wenzhou Medical University; Ningbo No.2 Hospital; Ningbo No.6 Hospital; Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University; Taizhou Hospital; Affiliated Wenling Hospital of Wenzhou Medical University; Lishui Country People's Hospital; The Fifth Hospital Affiliated to Wenzhou Medical University/ Lishui Central Hospital; Jinhua Municipal Central Hospital; Dongyang People's Hospital; People's Hospital of Quzhou
- First posted
- Jun 11, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The ANDES Platform Trial is a pragmatic, multicenter, adaptive randomized controlled platform trial in patients aged 65 years or older undergoing surgery for hip fracture. The trial evaluates whether enhanced anesthesia techniques reduce perioperative neurocognitive disorders compared with standard anesthesia care. The platform includes two randomization processes. In the first randomization, eligible participants are assigned to an active platform intervention-currently a preoperative regional nerve block or perioperative intravenous lidocaine infusion-or to a shared standard-anesthesia control. Participants for whom general anesthesia is planned may also enter a second, nested randomization and are assigned in a fixed 1:1 ratio to total intravenous anesthesia or volatile inhalational anesthesia, regardless of whether they participate in the first randomization. A non-surgical cognitive control cohort is included to characterize changes in cognitive test performance over time without exposure to surgery or study interventions. The Data Monitoring Committee reviews accumulating trial data and makes recommendations to the Trial Steering Committee, which determines whether platform interventions should continue, be modified, advance, or stop.
Conditions
- Anesthesia
- Hip Fractures
- Dementia
- Cognitive Impairment
- Cognitive Decline
Interventions
Nerve blockProcedure
Participants receive a preoperative regional nerve block as soon as possible after randomization. Ultrasound guidance is recommended, and fascia iliaca block is the recommended block technique.
Standard anesthesia careProcedure
Standard anesthesia care consists of routine general or regional anesthesia according to usual practice at each study center. Participants randomized to the shared control group do not receive protocol-specified trial interventions unless otherwise required by the Trial Steering Committee. Changes to standard anesthesia care are made in accordance with the prespecified adaptive decision framework. The independent Data Monitoring Committee reviews accumulating data and makes recommendations to the Trial Steering Committee, which makes the final platform decisions.
Bupivacaine liposomeDrug
For participants randomized to the nerve block group, 1.33% bupivacaine liposome is recommended as a long-acting local anesthetic, with a maximum dose not exceeding 133 mg, to maintain the continuity of the nerve block effect.
Regular local anestheticDrug
For participants randomized to the nerve block group, regular local anesthetic, such as bupivacaine or ropivacaine, may be used with continuous electronic analgesic pump infusion or multiple single injections to maintain the continuity of the nerve block effect.
Intravenous infusion of lidocaineDrug
Participants randomized to the lidocaine group receive ECG monitoring, oxygen saturation monitoring, blood pressure monitoring, and an open intravenous route on the morning of surgery. It is recommended to start the infusion of lidocaine as soon as possible in the ward. A portable electronic infusion pump is recommended for drug delivery. The loading dose is 1 mg/kg, and the maintenance dose range is 1 to 2 mg/kg/h. The specific dose is determined by the anesthesiologist according to the patient's condition. The infusion ends when the patient leaves the post-anesthesia care unit after surgery, and the infusion time and total amount are recorded. Intravenous infusion of lidocaine should be administered under ECG monitoring.
Total intravenous anesthesia maintenanceProcedure
Among participants who are eligible under the master protocol and for whom general anesthesia is planned, anesthetic maintenance may be assigned by the second nested randomization to total intravenous anesthesia maintenance in a 1:1 ratio. Total intravenous anesthesia maintenance is recommended to be mainly propofol-based, and analgesics such as remifentanil or fentanyl are recommended.
Volatile anesthesia maintenanceProcedure
Among participants who are eligible under the master protocol and for whom general anesthesia is planned, anesthetic maintenance may be assigned by the second nested randomization to volatile anesthesia maintenance in a 1:1 ratio. Following intravenous induction, anesthesia maintenance mainly with sevoflurane or isoflurane is recommended.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Neurocognitive Disorders (NCD) events rate during the first 7 postoperative daysTime frame: during the first 7 postoperative days
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Dongyang People's Hospital
Dongyang, Zhejiang, China · Enrolling by invitation
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China · Enrolling by invitation
Jinhua Municipal Central Hospital
Jinhua, Zhejiang, China · Recruiting
Lishui Central Hospital, the Fifth Hospital Affiliated to Wenzhou Medical University
Lishui, Zhejiang, China · Recruiting
Lishui People's Hospital
Lishui, Zhejiang, China · Recruiting
Ningbo No.2 Hospital
Ningbo, Zhejiang, China · Recruiting
Ningbo No.6 Hospital
Ningbo, Zhejiang, China · Recruiting
Quzhou People's Hospital
Quzhou, Zhejiang, China · Recruiting
Taizhou Central Hospital
Taizhou, Zhejiang, China · Enrolling by invitation
Zhejiang Taizhou Hospital
Taizhou, Zhejiang, China · Enrolling by invitation
The First People's Hospital of Wenling
Wenling, Zhejiang, China · Recruiting
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China · Enrolling by invitation
The Second Affilliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.